Search company, investor...

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

Founded Year



Series A - II | Alive

Total Raised


Last Raised

$3.05M | 3 yrs ago

About CytoSite Bio

Cytosite Bio is developing precision imaging products that determine patient response to immuno-oncology therapy very early in the treatment cycle. Its products detect active Granzyme B, the primary element responsible for the killing of tumor cells by the immune system. The company's products enable individually-optimized treatments for patients, and more rapid evaluation of new drugs and drug combinations, using non-invasive, whole-body PET imaging.

CytoSite Bio Headquarters Location

14 Petersen Circle

Sudbury, Massachusetts, 01776,

United States


Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing CytoSite Bio

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

CytoSite Bio is included in 5 Expert Collections, including Medical Devices.


Medical Devices

8,487 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.



3,605 items

Companies researching, developing, or offering products & services that aid in the screening, prevention, diagnosis, management, and treatment of cancer.


Health Monitoring & Diagnostics

2,412 items

Companies developing or offering products that aid in the assessment, screening, diagnosis, or monitoring of a person's state of health/wellness. Excludes companies focused solely on fitness/sports performance


Regenerative Medicine

1,818 items

Regenerative medicine refers to the process of activating, replacing, engineering or regenerating human genetic material, cells, tissues or organs to restore normal function. It also includes bioengineered tissues used for in vitro testing (e.g. organ-on-a-chip, organoids).


Health IT

7,901 items

CytoSite Bio Patents

CytoSite Bio has filed 2 patents.

The 3 most popular patent topics include:

  • EC 3.4.21
  • Immunology
  • Medical imaging
patents chart

Application Date

Grant Date


Related Topics



Medical imaging, Indoles, EC 3.4.21, Neuroimaging, Immunology


Application Date


Grant Date


Related Topics

Medical imaging, Indoles, EC 3.4.21, Neuroimaging, Immunology



  • When was CytoSite Bio founded?

    CytoSite Bio was founded in 2016.

  • Where is CytoSite Bio's headquarters?

    CytoSite Bio's headquarters is located at 14 Petersen Circle, Sudbury.

  • What is CytoSite Bio's latest funding round?

    CytoSite Bio's latest funding round is Series A - II.

  • How much did CytoSite Bio raise?

    CytoSite Bio raised a total of $7.87M.

  • Who are the investors of CytoSite Bio?

    Investors of CytoSite Bio include Acorn Campus Taiwan and U.S. Department of Health and Human Services.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.